Tubacex SA
Tubacex SA is a mining company engaged in the production and sale of copper and other base metals, primarily operating in Spain and other European countries.
Business. Tubacex SA (TUBA.MC) is a Basic Materials company operating in the Iron & Steel industry, primarily engaged in mining activities. The firm is headquartered in Spain and is listed on the BME (Madrid) exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
7 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Tubacex SA (TUBA.MC) is a Basic Materials company operating in the Iron & Steel industry, primarily engaged in mining activities. The firm is headquartered in Spain and is listed on the BME (Madrid) exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Tubacex operates with a fully diluted share count of 122.7 million shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability metrics for Tubacex are not available in the current dataset, and no direct comparison to industry medians can be made. However, the company's operations in the Iron & Steel industry suggest that it is subject to the same cyclical pressures and margin volatility as its peers.
Tubacex's revenue is concentrated in a few geographic regions, primarily in Spain and other parts of Europe. The company does not disclose detailed segment data, so the extent of geographic diversification is unclear.
The company's growth trajectory is not quantified in the current dataset, but analyst price targets suggest a range of expectations, with a mean of 4.37 EUR and a median of 4.15 EUR. The mean recommendation of 2.00 indicates a generally positive outlook from analysts.
Tubacex faces low dilution risk, as no dilutive instruments are currently outstanding. The absence of balance-sheet data prevents a full assessment of liquidity risk, but the company's capital structure appears stable.
Recent filings and transcripts are not available in the current dataset, so no specific events can be cited as influencing the company's performance or outlook.
- Tubacex operates in the Iron & Steel industry with a focus on copper and base metals.
- The company has no dilutive shares outstanding, indicating a stable capital structure.
- Analysts have a generally positive outlook, with a mean price target of 4.37 EUR.
- The company's liquidity risk could not be assessed due to missing balance-sheet data.
- Revenue concentration in Spain and Europe suggests exposure to regional economic conditions.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €164.4M, −3,9% YoY.
- ▍Revenue €164.4M, −3,9% YoY
Revenue €182.3M.
- ▍Revenue €182.3M
Revenue €171.1M.
- ▍Revenue €171.1M
Revenue €719.3M, −6,3% YoY; Operating income −85,9% YoY.
- ▍Revenue €719.3M, −6,3% YoY
- ▍Operating income −85,9% YoY
- ▍Net income −236,9% YoY
- ▍Free cash flow −105,7% YoY
- ▍Net margin -4.3%
Revenue €767.5M, −9,9% YoY; Operating income −21,3% YoY.
- ▍Revenue €767.5M, −9,9% YoY
- ▍Operating income −21,3% YoY
- ▍Net income −37,1% YoY
- ▍Free cash flow −301,1% YoY
- ▍Net margin 3.0%
Revenue €852.4M, +19,3% YoY; Operating income +81,6% YoY.
- ▍Revenue €852.4M, +19,3% YoY
- ▍Operating income +81,6% YoY
- ▍Net income +79,6% YoY
- ▍Free cash flow −63,1% YoY
- ▍Net margin 4.3%
Revenue €714.7M, +109,1% YoY; Operating income +242,8% YoY.
- ▍Revenue €714.7M, +109,1% YoY
- ▍Operating income +242,8% YoY
- ▍Net income +162,8% YoY
- ▍Free cash flow +308,7% YoY
- ▍Net margin 2.8%
Revenue €341.9M; Operating income -€31.1M.
- ▍Revenue €341.9M
- ▍Operating income -€31.1M
- ▍Net margin -9.4%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,12 |
| Revenue | —no estimate | —no estimate | 762,4M EUR |
| Operating income | —no estimate | —no estimate | 64,2M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Tubacex SA Market data — financials · 2026-05-29
- Tubacex SA Market data — analyst estimates · 2026-05-29
- Tubacex SA Market data — ESG · 2026-05-29
Ownership & reference
Leadership
- Jesus Esmoris EsmorisChief Executive Officer, Executive Director
- Josu Imaz MurguiondoChief Executive Officer, Executive Director